The global epilepsy drugs market is expected to reach over USD 5,474.14 million by 2024, according to a new report by Grand View Research, Inc. The rising government funding for the development of new and effective drugs for the treatment of seizures is a high impact rendering driver for the epilepsy drugs market growth. The American Epilepsy Society (AES) in alliance with other organizations, such as American Academy of Neurology, the Epilepsy Foundation, and the Grass Foundation, provide funding for R&D activities and offer treatment line awareness trainingto the physicians through different programs.
Furthermore, various awareness programs conducted by organizations, such as the Epilepsy Foundation, the American Epilepsy Society, Epilepsy Association of Central Florida, CURE Epilepsy, and the Anita Kaufmann Foundation, further accelerate the diagnosis and treatment rates. This is expected to propel the market growth over the forecast period.
Browse full research report on Global Epilepsy Drugs Market: http://www.grandviewresearch.com/industry-analysis/empty-capsules-market
Further key findings from the study suggest:
Read detailed report or request for sample of this research report:
Grand View Research has segmented the global epilepsy drugs market on the basis of treatment and region:
Global Epilepsy Drug market (Revenue, USD Million, 2013 – 2024)
Epilepsy Drugs Regional Outlook (Revenue, USD Million, 2013 – 2024)
Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/pharmaceuticals
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
Corporate Sales Specialist, USA
Grand View Research, Inc
All rights reserved• This document may not be used, copied nor changed without explicit consent of the author.